|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
26,320,000 |
Market
Cap: |
3.83(M) |
Last
Volume: |
169,426 |
Avg
Vol: |
167,840 |
52
Week Range: |
$0.1454 - $0.1454 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Co. is developing multiple precision-targeted products based on its Manocept platform to improve patient care by identifying the sites and pathways of undetected disease and enable diagnostic, clinical decision-making and targeted treatment. Co.'s business is focused on two primary types of drug products: diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform; and therapeutic development programs, including therapeutic applications of its Manocept platform.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Regan William J. |
SVP & Chief Compliance Officer |
|
2017-02-06 |
4 |
A |
$0.52 |
$41,161 |
D/D |
79,155 |
116,962 |
|
- |
|
Klima Thomas J |
SVP & Chief Commercial Officer |
|
2017-02-06 |
4 |
A |
$0.52 |
$26,460 |
D/D |
50,885 |
51,935 |
|
- |
|
Goldberg Michael M |
President & CEO |
|
2017-01-17 |
4 |
OE |
$0.01 |
$54,119 |
D/D |
5,411,850 |
5,815,002 |
|
- |
|
Greene Mark I |
Director |
|
2017-01-10 |
4 |
A |
$0.64 |
$10,500 |
D/D |
16,406 |
57,244 |
|
- |
|
Greene Mark I |
Director |
|
2016-10-17 |
4 |
A |
$0.87 |
$9,929 |
D/D |
11,413 |
40,838 |
|
- |
|
Goldberg Michael M |
Director |
|
2016-07-06 |
4 |
A |
$0.50 |
$21,790 |
D/D |
43,580 |
403,152 |
|
- |
|
Rice Yehuda Michael |
Director |
|
2016-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
28,000 |
|
- |
|
Greene Mark I |
Director |
|
2016-04-27 |
4 |
A |
$1.37 |
$1,952 |
D/D |
1,425 |
29,425 |
|
- |
|
Troup Gordon A |
Director |
|
2016-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
265,568 |
|
- |
|
Greene Mark I |
Director |
|
2016-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
28,000 |
|
- |
|
Goldberg Michael M |
Director |
|
2016-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
359,572 |
|
- |
|
Fiorino Anthony S. |
Director |
|
2016-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
28,000 |
|
- |
|
Rowinsky Eric K |
Director |
|
2016-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
224,446 |
|
- |
|
Rowinsky Eric K |
Director |
|
2016-04-08 |
4 |
A |
$1.14 |
$12,228 |
D/D |
10,726 |
196,446 |
|
- |
|
Gueth Anton |
Director |
|
2016-01-06 |
4 |
A |
$1.22 |
$20,640 |
D/D |
16,918 |
38,918 |
|
- |
|
Larson Brent L |
EVP, CFO, Treas & Secy |
|
2015-12-01 |
4 |
AS |
$1.50 |
$18,750 |
D/D |
(12,500) |
222,237 |
|
- |
|
Larson Brent L |
EVP, CFO, Treas & Secy |
|
2015-11-02 |
4 |
AS |
$1.98 |
$24,750 |
D/D |
(12,500) |
234,737 |
|
- |
|
Troup Gordon A |
Director |
|
2015-10-09 |
4 |
A |
$2.24 |
$11,769 |
D/D |
5,254 |
237,568 |
|
- |
|
Goldberg Michael M |
Director |
|
2015-10-08 |
4 |
A |
$2.26 |
$29,938 |
D/D |
13,247 |
331,572 |
|
- |
|
Larson Brent L |
EVP, CFO, Treas & Secy |
|
2015-10-01 |
4 |
AS |
$2.27 |
$28,375 |
D/D |
(12,500) |
247,237 |
|
- |
|
Larson Brent L |
EVP, CFO, Treas and Secy |
|
2015-09-01 |
4 |
AS |
$1.88 |
$23,516 |
D/D |
(12,500) |
259,737 |
|
- |
|
Larson Brent L |
EVP, CFO, Treas and Secy |
|
2015-08-03 |
4 |
AS |
$1.71 |
$21,330 |
D/D |
(12,500) |
272,237 |
|
- |
|
Ford Brendan A |
Director |
|
2015-07-31 |
4 |
A |
$1.61 |
$15,000 |
D/D |
9,317 |
239,950 |
|
- |
|
Troup Gordon A |
Director |
|
2015-07-26 |
4 |
A |
$1.61 |
$17,000 |
D/D |
10,559 |
232,314 |
|
- |
|
Karsen Perry A |
Director |
|
2015-07-16 |
4 |
D |
$0.01 |
$220 |
D/D |
(22,000) |
37,528 |
|
- |
|
190 Records found
|
|
Page 6 of 8 |
|
|